Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery

Clinical trial NCT06209294 · RECRUITING

Trial details

NCT number: NCT06209294
Sponsor: Xiaohua Wu
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neoadjuvant Immunotherapy Cervical Cancer Fertility-sparing Surgery

Start date: 2023-09-01
Primary completion: 2025-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.